Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $61.8 million.

  • Editas Medicine's Total Current Liabilities fell 1462.28% to $61.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year decrease of 1462.28%. This contributed to the annual value of $77.2 million for FY2024, which is 2215.86% up from last year.
  • Latest data reveals that Editas Medicine reported Total Current Liabilities of $61.8 million as of Q3 2025, which was down 1462.28% from $65.9 million recorded in Q2 2025.
  • Over the past 5 years, Editas Medicine's Total Current Liabilities peaked at $77.2 million during Q4 2024, and registered a low of $36.4 million during Q2 2022.
  • Its 5-year average for Total Current Liabilities is $59.4 million, with a median of $61.8 million in 2025.
  • In the last 5 years, Editas Medicine's Total Current Liabilities tumbled by 4483.0% in 2022 and then soared by 5657.62% in 2023.
  • Quarter analysis of 5 years shows Editas Medicine's Total Current Liabilities stood at $46.9 million in 2021, then rose by 28.21% to $60.1 million in 2022, then grew by 5.17% to $63.2 million in 2023, then grew by 22.16% to $77.2 million in 2024, then decreased by 20.01% to $61.8 million in 2025.
  • Its Total Current Liabilities stands at $61.8 million for Q3 2025, versus $65.9 million for Q2 2025 and $73.1 million for Q1 2025.